This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1991 Dec;23(6):3175-8.

Neurologic complications of FK 506

B H Eidelman¹, K Abu-Elmagd, J Wilson, J J Fung, M Alessiani, A Jain, S Takaya, S N Todo, A Tzakis, D Van Thiel, et al.

Affiliations

PMID: 1721398
PMCID: PMC2964000

Comparative Study

Neurologic complications of FK 506

B H Eidelman et al. Transplant Proc. 1991 Dec.

. 1991 Dec;23(6):3175-8.

Authors

B H Eidelman¹, K Abu-Elmagd, J Wilson, J J Fung, M Alessiani, A Jain, S Takaya, S N Todo, A Tzakis, D Van Thiel, et al.

Affiliation

¹ Department of Neurology, University of Pittsburgh School of Medicine, PA 15261.

PMID: 1721398
PMCID: PMC2964000

No abstract available

PubMed Disclaimer

Figures

Fig 1 — Fig 1
Average daily bilirubin levels in the two patient groups during the first 60 days posttransplantation, trough plasma FK 506 levels in the same patients, and daily doses of FK 506 are shown. A total of 215 patients with no neurotoxicity and 14 patients with signs of neurotoxicity are shown, which do not represent all of the prospective patients.

Fig 2 — Fig 2
Posttransplant course of a 48-year-old cardiac transplant recipient. Elevated blood urea nitrogen and creatinine during the first 2 weeks was related to perioperative hypotension with secondary renal failure. Neurologic dysfunction was characterized by an encephalopathy with concomitant rising plasma FK 506 level.

See this image and copyright information in PMC

Similar articles

Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK 506.
Lopez OL, Martinez AJ, Torre-Cisneros J. Lopez OL, et al. Transplant Proc. 1991 Dec;23(6):3181-2. Transplant Proc. 1991. PMID: 1721400 Clinical Trial. No abstract available.
Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients.
Felser I, Wagner S, Depee J, Johnson N, Staschak S, Jain A, Fung JJ, Starzl TE. Felser I, et al. Transplant Proc. 1991 Dec;23(6):3032-4. Transplant Proc. 1991. PMID: 1721350 Free PMC article. No abstract available.
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.
Carroll PB, Rilo H, Reyes J, Alejandro R, Zeng Y, Ricordi C, Tzakis A, Shapiro R, Starzl TE. Carroll PB, et al. Transplant Proc. 1991 Dec;23(6):3171-2. Transplant Proc. 1991. PMID: 1721396 Free PMC article. No abstract available.
Tacrolimus (FK 506) in kidney transplantation.
Vanrenterghem Y. Vanrenterghem Y. Transplant Proc. 1998 Aug;30(5):2171-3. doi: 10.1016/s0041-1345(98)00578-8. Transplant Proc. 1998. PMID: 9723431 Review. No abstract available.
Neurotoxicity of calcineurin inhibitors: impact and clinical management.
Bechstein WO. Bechstein WO. Transpl Int. 2000;13(5):313-26. doi: 10.1007/s001470050708. Transpl Int. 2000. PMID: 11052266 Review.

See all similar articles

Cited by

Posterior Reversible Encephalopathy Syndrome in Kidney Disease.
Ganesh K, Nair RR, Kurian G, Mathew A, Sreedharan S, Paul Z. Ganesh K, et al. Kidney Int Rep. 2017 Nov 11;3(2):502-507. doi: 10.1016/j.ekir.2017.10.017. eCollection 2018 Mar. Kidney Int Rep. 2017. PMID: 29725657 Free PMC article. No abstract available.
A risk-benefit assessment of tacrolimus in transplantation.
Winkler M, Christians U. Winkler M, et al. Drug Saf. 1995 May;12(5):348-57. doi: 10.2165/00002018-199512050-00006. Drug Saf. 1995. PMID: 7545405 Review.
Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations.
Tremblay S, Alloway RR. Tremblay S, et al. AAPS J. 2017 Sep;19(5):1332-1347. doi: 10.1208/s12248-017-0119-z. Epub 2017 Jul 17. AAPS J. 2017. PMID: 28717926 Review.
Adverse effects of FK 506 overdosage after liver transplantation.
Alessiani M, Cillo U, Fung JJ, Irish W, Abu-Elmagd K, Jain A, Takaya S, Van Thiel D, Starzl TE. Alessiani M, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):628-34. Transplant Proc. 1993. PMID: 7679825 Free PMC article. No abstract available.
Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study.
Giral M, Grimbert P, Morin B, Bouvier N, Buchler M, Dantal J, Garrigue V, Bertrand D, Kamar N, Malvezzi P, Moreau K, Athea Y, Le Meur Y. Giral M, et al. Transpl Int. 2024 Apr 17;37:11571. doi: 10.3389/ti.2024.11571. eCollection 2024. Transpl Int. 2024. PMID: 38694490 Free PMC article.

See all "Cited by" articles

References

1. Inamura N, Nakahara K, Kino T, et al. Transplantation. 1988;45:206. - PubMed
1. Goto S, Stepkowski SM, Kahan BD. Transplant Proc. 1991;23:529. - PubMed
1. Jiang H, Takahara S, Takano Y, et al. Transplant Proc. 1991;23:540. - PubMed
1. Tzakis AG, Fung JJ, Todo J, et al. Transplant Proc. 1991;23:924. - PMC - PubMed
1. Jain AB, Fung JJ, Todo S, et al. Transplant Proc. 1991;23:928. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

R01 DK029961/DK/NIDDK NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information